AXQ Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

AXQ Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$260K	Sell	12,147 -20,258	-63%	-$285K	0.03%	641
2025 Q4	$302K	Buy	32,405 +16,099	+99%	+$134K	0.07%	440
2025 Q3	$115K	Buy	+16,306	New	+$112K	0.04%	507
2025 Q2	–	Sell	-19,030	Closed	-$151K	–	614
2025 Q1	$151K	Buy	+19,030	New	+$205K	0.06%	424
2024 Q4	–	Sell	-10,125	Closed	-$141K	–	484
2024 Q3	$141K	Buy	+10,125	New	+$144K	0.04%	394
2023 Q2	–	Sell	-23,070	Closed	-$308K	–	356
2023 Q1	$308K	Buy	+23,070	New	+$451K	0.12%	297

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

AXQ Capital's DAWN Position: Q1 2026 in Review

AXQ Capital reduced its Day One Biopharmaceuticals (DAWN) stake by 63% in Q1 2026, selling an estimated $285K and leaving 12,147 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #641.

AXQ Capital first reported a position in DAWN in Q1 2023 and has held it in 6 quarters since. The position peaked at $308K in Q1 2023. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

AXQ Capital held 12,147 shares of Day One Biopharmaceuticals worth $260K as of Q1 2026.
AXQ Capital sold 20,258 Day One Biopharmaceuticals shares in Q1 2026, an estimated $285K.
Day One Biopharmaceuticals made up 0.03% of AXQ Capital's portfolio in Q1 2026, its #641 holding.
AXQ Capital first reported a position in Day One Biopharmaceuticals in Q1 2023 and has held it in 6 quarters since.
AXQ Capital's Day One Biopharmaceuticals position peaked at $308K in Q1 2023.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.